One-Pot Synthesis of Primary and Secondary Aliphatic Amines via Mild and Selective sp3 C-H Imination.

The direct replacement of sp3 C-H bonds with simple amine units (-NH2 ) remains synthetically challenging, although primary aliphatic amines are ubiquitous in medicinal chemistry and natural product synthesis. We report a mild and selective protocol for preparing primary and secondary aliphatic amines in a single pot, based on intermolecular sp3 C-H imination. The first C-H imination of diverse alkanes, this method shows useful site-selectivity within substrates bearing multiple sp3 C-H bonds. Furthermore, this reaction tolerates polar functional groups relevant for complex molecule synthesis, highlighted in the synthesis of amine pharmaceuticals and amination of natural products. We characterize a unique C-H imination mechanism based on radical rebound to an iminyl radical, supported by kinetic isotope effects, stereoablation, resubmission, and computational modeling. This work constitutes a selective method for complex amine synthesis and a new mechanistic platform for C-H amination.

Design, synthesis and antitumor activity of novel 4-methyl-(3'S,4'S)-cis-khellactone derivatives.

An asymmetric synthesis of a series of novel 4-methyl-(3'S,4'S)-cis-khellactone derivatives 3a-o is reported for the first time. Their structures were confirmed by 1H-NMR, 13C-NMR and MS. Their cytotoxic activity was evaluated by the MTT assay against three selected human cancer cell lines: HEPG-2 (human liver carcinoma), SGC-7901 (human gastric carcinoma), LS174T (human colon carcinoma). Some compounds showed high inhibitory activity against these human cancer cell lines. Among them, compound 3a exhibited strong cytotoxicity, with IC50 values ranging from 8.51 to 29.65 µM. The results showed that 4-methyl-cis-khellactone derivatives with S,S configuration could be a potential antitumor agents.

ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.

Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase of the insulin receptor kinase subfamily, is activated in multiple cancer types through translocation or overexpression. Although several generations of ALK tyrosine kinase inhibitors (TKIs) have been developed for clinic use, drug resistance remains a major challenge. In this study, by quantitative proteomic approach, we identified the glycolytic regulatory enzyme, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), as a new target of ALK. Expression of PFKFB3 is highly dependent on ALK activity in ALK+ anaplastic large cell lymphoma and non-small-cell lung cancer (NSCLC) cells. Notably, ALK and PFKFB3 expressions exhibit significant correlation in clinic ALK+ NSCLC samples. We further demonstrated that ALK promotes PFKFB3 transcription through the downstream transcription factor STAT3. Upregulation of PFKFB3 by ALK is important for high glycolysis level as well as oncogenic activity of ALK+ lymphoma cells. Finally, targeting PFKFB3 by its inhibitor can overcome drug resistance in cells bearing TKI-resistant mutants of ALK. Collectively, our studies reveal a novel ALK-STAT3-PFKFB3 axis to promote cell proliferation and tumorigenesis, providing an alternative strategy for the treatment of ALK-positive tumors.

A ring-shaped random laser in momentum space.

A ring-shaped random laser in momentum space is designed by directly coupling a random laser with a commercial optical fiber. By using a simple approach of selectively coating the random gain layer on the surface of the fiber, red and yellow random lasers are respectively achieved with low threshold values and a good emission direction due to the guiding role of optical fibers. The unique coupling mechanism leads to a random laser with a ring shape in momentum space, which is an excellent illuminating source for high-quality imaging with an extremely low speckle noise. More importantly, a triple-state color-switchable random laser with yellow, red and yellow-red dual-colors can be flexible, and is obtained by simply moving the pump position. The results may promote the practical applications of random lasers in the fields of sensing, in vivo biological imaging, and high brightness full-field illumination.

Solvent-Assisted Stepwise Redox Approach To Generate Zeolite NaA-Supported K2O as Strong Base Catalyst for Michael Addition of Ethyl Acrylate with Ethanol.

Solid base catalysts featuring green, robustness, and high activity play an important role in the current fine-chemical and petrochemical industry. Normally, the generation of supported K2O by thermal decomposition of KNO3 requires high temperature, and this process can sometimes destroy the structure of supporting materials. We herein report a solvent-assisted stepwise redox (SASR) approach to generate zeolite NaA-supported K2O, which we call K2O/NaA, that function as the solid base catalyst for Michael addition reaction between ethanol and ethyl acrylate. The solvent-assisted redox decomposition process of KNO3 at elevated temperature was investigated by thermogravimetry-mass spectrometry. It reveals that after reducing a minor amount of KNO3 at 400 °C, the organic solvent decomposes to form carbon, which promotes the reduction of KNO3 to generate strong basicity on the zeolite NaA at 600 °C. The resulting material, K2O/NaA-S, exhibits improved catalytic activity in Michael addition reaction over other benchmark base catalysts that have been used in this reaction. This catalyst is durable for at least four catalytic cycles without apparent loss in activity. K2O/NaA-S exhibits larger reaction rate constant yet lower activation energy than K2O/NaA prepared by thermal decomposition method. The SASR approach described in this paper represents a new blueprint for the generation of the supported alkali oxide as the solid base catalyst.